Weight Regain After Bariatric Surgery: How Common, and Why
Regain after a sleeve is common, and its rate depends mostly on which definition the study picked, not only on the patients.

There is a formula for deciding whether someone who had weight-loss surgery has regained weight, and it involves a percentage of a percentage of a number that is partly hypothetical. The formula is a real one, from a 2022 review in Frontiers in Endocrinology, and it is not the only one. Several of them are in circulation, and each gives a different answer (which is a lot of answers for one bathroom scale).
So here is the plain answer to weight regain after gastric sleeve, as far as the facts allow: it is common, the sleeve is more prone to it than the bypass or the duodenal switch, and the exact rate depends heavily on which definition the study used. Average total weight loss after a sleeve runs about 25 to 30% at two to five years and about 24.4% at ten years. In one Polish ten-year study, 24.3% of sleeve patients needed a revisional operation. Another study says up to half of sleeve patients may eventually need conversion surgery. The causes, per that same review, are “multifactorial.”
What counts as weight regain, starting small
Start with the most reasonable definition possible. A person has surgery, loses weight, and at some point hits their lowest weight, which the literature calls the nadir. Anything above the nadir is regain. Simple.
Here is a patient I am making up. She weighs 300 lb, has a sleeve, gets down to 200, and a couple of years later weighs 210. By the simple definition she has regained weight. The trouble is that a lowest weight is, by construction, the lowest. Nearly every weight recorded after it will be higher (that is what “lowest” means). A definition that catches everyone tells you very little.
So you add a threshold. The Frontiers review defines weight recurrence as “an increase of 25% excess weight loss from nadir weight.” Unpacking that takes a minute. “Excess weight” is the weight above some reference healthy weight. Say, in our made-up case, the reference is 150 lb, so she started with 150 lb of excess. She lost 100 of them. Her regain counts once she has put back 25% of that 100, which is 25 lb. At 210 she is fine. At 225 she has recurrence.
This is like measuring your progress in a grocery line as a fraction of the people who were ahead of you when you arrived, and then measuring any backsliding as a fraction of that progress. It works. It is just two layers removed from “how much do I weigh.”
Escalating the definition until it means whatever you want
Now add a second definition from a different study. The BARI-STEP trial, which tested semaglutide in people who had not done well after surgery, defined a “suboptimal clinical response” as less than 20% weight loss from surgery. That is measured from the starting weight, not the nadir. Our made-up patient at 240 lb has lost exactly 20% of her original 300. Under BARI-STEP she is borderline acceptable. Under Frontiers, at 240, she has regained 40 lb, well past her 25-lb threshold. She is a recurrence and not a failure at the same time.
Keep going. Suppose every research group picks its own threshold (15%, 25%, 50% of excess weight loss), its own reference weight, its own starting point, its own follow-up window, etc. At the far end of this road, the regain rate stops being a fact about patients and becomes a fact about the methods section. Pick a strict enough definition and the rate approaches 100%. Pick a loose one and it approaches zero. It is a batting average where each team decides which at-bats count.
How far along that road is the real world? Pretty far. A pouch-resizing study says weight regain affects 10 to 30% of bypass patients, which is a range wide enough to drive a definition through. Diabetes relapse after surgery, a related problem with the same measurement headaches, is reported anywhere from about 10% to over 60%. And I would rather not think about what the people drafting the next consensus definition have planned.
Everyone involved is behaving sensibly, though. Surgeons want a threshold that flags a real problem rather than normal drift. Researchers want a number they can compare across trials, and inherited whatever definition their field already used. Patients want to know whether the scale is telling them something. Those are three different questions, and one formula cannot answer all of them.
How common is weight regain after gastric sleeve, by the numbers
With that caveat stamped on everything, here is what the numbers say. A review of laparoscopic sleeve outcomes put total body weight loss at 25 to 30% at two to five years. A review of very long-term results put the sleeve at 24.4% at ten years, the lowest of the operations it compared, against roughly 40% for the duodenal switch. In the Oseberg randomized trial, the sleeve produced 17.2% total weight loss at five years versus 22.2% for gastric bypass.
Then there are revisions. In the BARI-10-POL study from Poland, 23.9% of patients needed a revisional procedure over ten years, including 24.3% of sleeve patients and 100% of adjustable gastric band patients (lol, the band has its own article). A seven-year study of conversions put it more starkly: “Up to half of sleeve gastrectomy patients may require conversion surgery due to insufficient weight loss, weight recurrence, or complications.” Note that this lumps regain together with reflux and other complications, so it is not a pure regain rate.
Small studies give scarier numbers. A prospective study in endometrial cancer patients found weight regain by two years in 66.7% of the sleeve group and 55.6% of the semaglutide group, against 14.3% in a lifestyle program. These were small groups in a specific population, and I don’t know how much to generalize from them. Probably not a lot.
For comparison, the LABS study found that bypass patients regained a mean 3.9% of baseline weight between years three and seven. And the Frontiers review says the duodenal switch is not associated with high rates of regain because its malabsorption makes it “physiologically more complex to regain weight.” The stronger the plumbing change, the less the weight comes back. That pattern holds.
Why the weight comes back
The full Frontiers list of contributors is “genetic, psychological, behavioral, anatomic, and technical factors.” Which is, in some sense, a list of every category of thing that exists. I mean that sympathetically. A sleeve changes a stomach. It does not change a genome, a job, a sleep schedule, or whatever else is going on in a life.
The anatomic and technical items are the ones specific to surgery: how the operation was built and whether it has changed since. The others are the ones that were there before the surgery and presumably still are. Sorting a given patient into those buckets is most of the work.
And the regain matters for health, not just for the scale. The same review says recurrence is associated with the reappearance of weight-related comorbidities. Here the operations split again. Surgery has metabolic effects that are partly independent of weight loss, per a review in Clinical Diabetology, and those effects seem stronger after bypass. A Mayo Clinic study found 75% of bypass patients kept their diabetes in remission at five years despite regain, versus 34.8% after sleeve. In the DIABETCIR trial, remission persisted at ten years in 3 of 12 sleeve patients. Regain after a sleeve tends to bring more back with it.
What an evaluation is actually sorting out
The clinic version of all this sounds something like: “Okay, you’re up 22 lb from your lowest, which by our definition isn’t recurrence yet, but let’s figure out why.” (I invented that, but I assume it is said somewhere every day.) The evaluation is mostly sorting: is this the anatomy, the original technique, or one of the factors the operation never touched? The facts here do not lay out a standard workup, and I won’t pretend they do.
What comes after the sorting is ground the site covers elsewhere, so briefly. In one multicenter study of people with prior sleeves, converting to bypass produced 26.1% total weight loss at three years versus 13.7% with GLP-1 drugs. A meta-analysis found SADI beat one-anastomosis bypass on weight at one year as a revision, and leakage was the most common major complication of that one-anastomosis revision. The ESG review says endoscopic suturing works as a revision after non-resective procedures, which a sleeve, having had most of the stomach removed, is not. And a 2026 review notes significant regain when incretin drugs are stopped, so drugs carry their own version of the problem.
My job, for what it’s worth, mostly consists of reading other people’s denominators (a hobby that does not come up well at parties). It’s fine. The denominators are where the action is.
Which brings us back to the formula. It still runs on a reference weight that is partly hypothetical, a nadir that is by definition the bottom, and a percentage of a percentage. Our made-up patient can be a recurrence and a success on the same day, depending on which paper is open. The definition is negotiable. The weight is not.
Sources
- Pouch Resizing for Weight Regain after Roux-En-Y Gastric Bypass: Results from a High-Volume Single Center
- A Comprehensive Review of Sleeve Gastrectomy, Roux-en-Y Gastric Bypass, One-Anastomosis Gastric Bypass, Duodenal Switch, and SADI-S: Very Long-Term Outcomes at 10 Years and Beyond
- Gastric Bypass Improves Long-Term Diabetes Remission, Even After Weight Recurrence | ACS
- Continued Diabetes Remission Despite Weight Recurrence: Gastric Bypass Long-Term Metabolic Benefit.
- Comparison of lifestyle, surgery, and semaglutide for weight management in endometrial cancer: a prospective observational study
- Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial.
- Seven-Year Comparative Outcomes of One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass for Weight Recurrence Regain Post Sleeve Gastrectomy
- Long-term outcomes of metabolic bariatric surgery: a 10-Year multicenter retrospective study in Poland (BARI-10-POL)
- Frontiers | Endoscopic Management of Weight Recurrence Following Bariatric Surgery
- Bariatric Surgery and Type 2 Diabetes Remission and Relapse: Mechanisms, Predictive Factors, and Postoperative Management — a Review Article | Ciesielska | Clinical Diabetology
- Laparoscopic Single Anastomosis Duodeno-Ileal Bypass Versus One Anastomosis Gastric Bypass as Revisional Procedures after Sleeve Gastrectomy: Meta-analysis and Systematic Review
- Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial
- One Anastomosis/Mini-Gastric Bypass (OAGB/MGB) as Revisional Surgery Following Primary Restrictive Bariatric Procedures: a Systematic Review and Meta-Analysis
- Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study
- Incretin-Based Therapies Versus Bariatric and Metabolic Surgery for Obesity and Type 2 Diabetes Mellitus: A Head-to-Head Systematic Review of Glycaemic, Cardiovascular, Hepatic, Weight, and Quality-of-Life Outcomes
- Sleeve-to-bypass conversion vs. sleeve-with-adjuvant GLP-1 receptor agonists: an academic multicenter retrospective study
- Shaping the Future of Restrictive Bariatric Surgery: Clinical, Economic, and Long-Term Perspectives on Endoscopic and Laparoscopic Sleeve
- Diabetes remission 10 years after bariatric surgery: Extension study of a randomized controlled trial
- Endoscopic Sleeve Gastroplasty: A Qualitative Narrative Review of Outcomes, Safety, and Clinical Applications
Bariatric Alt explains published research. It is not medical advice, and it never recommends a surgeon, a clinic, a dose or a product. Talk to a clinician about which option fits you.